Delivery Order SPE2DB22D1106-SPE2DB25FFGH5
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,053.93 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glycopyrrolate 0.2 mg/mL vials. This firm fixed-price, non-set-aside contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Glycopyrrolate 0.2 mg/mL in 5 mL vials, with a ceiling value of $14,491.55 and an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be fulfilled at the contractor's Conshohocken, Pennsylvania facility. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,955.44 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 1 mg/5 mL vials (5 mL units). This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 3, 2025. The product will be supplied from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,379.02 delivery order to AmerisourceBergen Drug Corp for Glycopyrrolate Inject, with an ultimate completion date of June 26, 2024. This non-set-aside, firm fixed price contract was competitively awarded on June 25, 2024, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical transaction within the company's broader federal medical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,685.05, is for the delivery of glycopyrrolate 1 mg/5 ml vials. This is a firm fixed-price delivery order contract with a completion date of June 12, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a $2,443.72 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The order is for the supply of 2 ml vials of glycopyrrolate 0.2 mg/ml to support military treatment programs and facilities. The delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of GLYCOPYRROLATE INJECT, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $8,856.68 and a completion date of May 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide glycopyrrolate 4 mg/20 ml vials. The contract, valued at $1,366.76, is a firm fixed-price delivery order with a completion date of May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
- This is a $3,782.55 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product. The contract has an ultimate completion date of August 20, 2024. Amerisourcebergen is a key supplier of a wide range of medical commodities, including prescription medications, vaccines, and medical supplies, to various federal agencies and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,774.29, is a firm fixed price delivery order for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a period of performance through July 7, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery...